These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33882092)

  • 1. Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
    Bachanas P; Alwano MG; Lebelonyane R; Block L; Behel S; Raizes E; Ussery G; Wang H; Ussery F; Pretorius Holme M; Sexton C; Pals S; Lasry A; Del Castillo L; Hader S; Lockman S; Bock N; Moore J
    PLoS One; 2021; 16(4):e0250211. PubMed ID: 33882092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
    Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
    Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
    Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).
    Marukutira T; Block L; Alwano MG; Behel S; Jarvis JN; Chakalisa U; Powis K; Novitsky V; Bapati W; Wang H; Ussery F; Lebelonyane R; Mills LA; Moore J; Bachanas P
    PLoS One; 2019; 14(8):e0221629. PubMed ID: 31465494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Abrams W; Roland M; Theu J; Kapanda M; Matambo S; Lockman S; Gaolathe T; Makhema J; Moore J; Jarvis JN
    Lancet HIV; 2020 Aug; 7(8):e545-e553. PubMed ID: 32763218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
    Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
    J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project.
    Alwano MG; Bachanas P; Block L; Roland M; Sento B; Behel S; Lebelonyane R; Wirth K; Ussery F; Bapati W; Motswere-Chirwa C; Abrams W; Ussery G; Miller JA; Bile E; Fonjungo P; Kgwadu A; Holme MP; Del Castillo L; Gaolathe T; Leme K; Majingo N; Lockman S; Makhema J; Bock N; Moore J
    PLoS One; 2019; 14(11):e0225076. PubMed ID: 31765394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.
    Gaolathe T; Wirth KE; Holme MP; Makhema J; Moyo S; Chakalisa U; Yankinda EK; Lei Q; Mmalane M; Novitsky V; Okui L; van Widenfelt E; Powis KM; Khan N; Bennett K; Bussmann H; Dryden-Peterson S; Lebelonyane R; El-Halabi S; Mills LA; Marukutira T; Wang R; Tchetgen EJ; DeGruttola V; Essex M; Lockman S;
    Lancet HIV; 2016 May; 3(5):e221-30. PubMed ID: 27126489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
    Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C
    PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
    Makhema J; Wirth KE; Pretorius Holme M; Gaolathe T; Mmalane M; Kadima E; Chakalisa U; Bennett K; Leidner J; Manyake K; Mbikiwa AM; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Lebelonyane R; Alwano MG; Powis KM; Dryden-Peterson SL; Kgathi C; Novitsky V; Moore J; Bachanas P; Abrams W; Block L; El-Halabi S; Marukutira T; Mills LA; Sexton C; Raizes E; Gaseitsiwe S; Bussmann H; Okui L; John O; Shapiro RL; Pals S; Michael H; Roland M; DeGruttola V; Lei Q; Wang R; Tchetgen Tchetgen E; Essex M; Lockman S
    N Engl J Med; 2019 Jul; 381(3):230-242. PubMed ID: 31314967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Coverage of Antiretroviral Treatment With Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings From the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019.
    Pathmanathan I; Nelson R; de Louvado A; Thompson R; Pals S; Casavant I; Cardoso MJA; Ujamaa D; Bonzela J; Mikusova S; Chivurre V; Tamele S; Sleeman K; Zhang G; Zeh C; Dobbs T; Vubil A; Auld A; Briggs-Hagen M; Vergara A; Couto A; MacKellar D
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e97-e105. PubMed ID: 33252546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
    Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
    J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
    PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
    van Rooyen H; Barnabas RV; Baeten JM; Phakathi Z; Joseph P; Krows M; Hong T; Murnane PM; Hughes J; Celum C
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):e1-8. PubMed ID: 23714740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.
    Marukutira T; Yin D; Cressman L; Kariuki R; Malone B; Spelman T; Mawandia S; Ledikwe JH; Semo BW; Crowe S; Stoove M; Hellard M; Dickinson D
    Medicine (Baltimore); 2019 Jun; 98(23):e15994. PubMed ID: 31169739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.